Skip to main content

Table 3 Percentage of participants with drug intake by baseline BMI group

From: Impact of BMI and BMI change on future drug expenditures in adults: results from the MONICA/KORA cohort study

  

Total

By BMI group

 
   

Normal weight

Overweight

Moderate obesity

Severe obesity

p-valuea

  

n = 2,946

n = 1,064

n = 1,327

n = 434

n = 121

 

Percentage

 

67.9%

60.3%

68.6%

78.8%

90.1%

<.0001

Percentage by ATC group

A: Alimentary tract and metabolism

16.3%

8.6%

17.3%

25.1%

42.1%

<.0001

B: Blood and blood-forming organs

13.5%

7.9%

15.7%

18.7%

21.5%

0.3732

C: Cardiovascular system

36.9%

19.1%

40.5%

60.1%

70.2%

<.0001

 

G: Genitourinary system and sex hormones

12.8%

16.7%

10.8%

9.2%

14.0%

0.2158

 

H: Systemic hormonal preparations, excl. sex hormones + insulins

14.8%

12.9%

13.6%

19.8%

28.1%

0.0004

 

M: Musculoskeletal system

16.5%

11.6%

16.3%

27.0%

24.8%

<.0001

 

N: Nervous system

16.4%

14.9%

16.2%

20.0%

19.0%

0.5355

 

R: Respiratory system

8.2%

7.7%

8.1%

9.4%

9.1%

0.4434

  1. ap-values were adjusted for age, sex and SES.